Literature DB >> 9619776

Bootstrapping for pharmacokinetic models: visualization of predictive and parameter uncertainty.

C A Hunt1, G H Givens, S Guzy.   

Abstract

PURPOSE: We explore use of "bootstrapping" methods to obtain a measure of reliability of predictions made in part from fits of individual drug level data with a pharmacokinetic (PK) model, and to help clarify parameter identifiability for such models.
METHODS: Simulation studies use four sets (A-D) of drug concentration data obtained following a single oral dose. Each set is fit with a two compartment PK model, and the "bootstrap" is employed to examine the potential predictive variation in estimates of parameter sets. This yields an empirical distribution of plausible steady state (SS) drug concentration predictions that can be used to form a confidence interval for a prediction.
RESULTS: A distinct, narrow confidence region in parameter space is identified for subjects A and B. The bootstrapped sets have a relatively large coefficient of variation (CV) (35-90% for A), yet the corresponding SS drug levels are tightly clustered (CVs only 2-9%). The results for C and D are dramatically different. The CVs for both the parameters and predicted drug levels are larger by a factor of 5 and more. The results reveal that the original data for C and D, but not A and B, can be represented by at least two different PK model manifestations, yet only one provides reliable predictions.
CONCLUSIONS: The insights gained can facilitate making decisions about parameter identifiability. In particular, the results for C and D have important implications for the degree of implicit overparameterization that may exist in the PK model. In cases where the data support only a single model manifestation, the "bootstrap" method provides information needed to form a confidence interval for a prediction.

Entities:  

Mesh:

Year:  1998        PMID: 9619776     DOI: 10.1023/a:1011958717142

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  9 in total

1.  Structure and parameterization of pharmacokinetic models: their impact on model predictions.

Authors:  T J Woodruff; F Y Bois; D Auslander; R C Spear
Journal:  Risk Anal       Date:  1992-06       Impact factor: 4.000

2.  Similarity transformation approach to identifiability analysis of nonlinear compartmental models.

Authors:  S Vajda; K R Godfrey; H Rabitz
Journal:  Math Biosci       Date:  1989-04       Impact factor: 2.144

3.  Multiple solutions, illegal parameter values, local minima of the sum of squares, and anomalous parameter estimates in least-squares fitting of the two-compartment pharmacokinetic model with absorption.

Authors:  R D Purves
Journal:  J Pharmacokinet Biopharm       Date:  1996-02

4.  Validation of a decision support system for use in drug development: pharmacokinetic data.

Authors:  S Guzy; C A Hunt
Journal:  Pharm Res       Date:  1997-10       Impact factor: 4.200

5.  Measures of uncertainty of pharmacokinetic and pharmacodynamic parameter estimates: a new computerized algorithm.

Authors:  S Guzy; C A Hunt
Journal:  Comput Biomed Res       Date:  1996-12

Review 6.  The problem of model indistinguishability in pharmacokinetics.

Authors:  K R Godfrey; M J Chapman
Journal:  J Pharmacokinet Biopharm       Date:  1989-04

7.  Optimization issues in physiological toxicokinetic modeling: a case study with benzene.

Authors:  T J Woodruff; F Y Bois
Journal:  Toxicol Lett       Date:  1993-08       Impact factor: 4.372

8.  Simulation studies of errors of parameter estimates in pharmacokinetics.

Authors:  G Betzien; B Kaufmann; B Schneider; W A Ritschel
Journal:  Arzneimittelforschung       Date:  1985

9.  A simulation study of parameter estimation in the one and two compartment models.

Authors:  P M Laskarzewski; D L Weiner; L Ott
Journal:  J Pharmacokinet Biopharm       Date:  1982-06
  9 in total
  3 in total

1.  The h subunit of eIF3 promotes reinitiation competence during translation of mRNAs harboring upstream open reading frames.

Authors:  Bijoyita Roy; Justin N Vaughn; Byung-Hoon Kim; Fujun Zhou; Michael A Gilchrist; Albrecht G Von Arnim
Journal:  RNA       Date:  2010-02-23       Impact factor: 4.942

2.  Quantification of Radiation Injury on Neutropenia and the Link between Absolute Neutrophil Count Time Course and Overall Survival in Nonhuman Primates Treated with G-CSF.

Authors:  John Harrold; Per Olsson Gisleskog; Isabelle Delor; Philippe Jacqmin; Juan Jose Perez-Ruixo; Adimoolam Narayanan; Sameer Doshi; Andrew Chow; Bing-Bing Yang; Murad Melhem
Journal:  Pharm Res       Date:  2020-05-21       Impact factor: 4.200

3.  A phase I/IIa trial of atorvastatin in Japanese patients with acute Kawasaki disease with coronary artery aneurysm: Study protocol of a multicenter, single-arm, open-label trial.

Authors:  Yo Murata; Reina Isayama; Shoko Imai; Kensuke Shoji; Mizuho Youndzi; Mami Okada; Masashi Mikami; Shinobu Kobayashi; Kevin Y Urayama; Tohru Kobayashi
Journal:  Contemp Clin Trials Commun       Date:  2022-01-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.